References
- Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1758788
- Bride, M. C., Marjorie, V. Z., & Burtram, C. F. (2014). The coronavirus Nucleocapsid is a multifunctional protein. Viruses, 6, 2991–3018. https://doi.org/https://doi.org/10.3390/v6082991
- Brito, M. A. (2011). Pharmacokinetic study with computational tools in the medicinal chemistry course. Brazilian Journal of Pharmaceutical SciencesSciences, 47(4), 797–805. https://doi.org/https://doi.org/10.1590/S1984-82502011000400017
- Chandel, V., Srivastava, M., Srivastava, A., Asthana, S., & Kumar, D. (2020). In-silico interactions of active phytochemicals with c-Myc EGFR and ERBB2 oncoproteins. Chemical Biology Letters, 7(1), 47–54.
- Chaudhuri, S., Symons, J. A., & Deval, J. (2018). Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond. Antiviral Researchres, 155, 76–88. https://doi.org/https://doi.org/10.1016/j.antiviral.2018.05.005
- Chu, M., Xu, L., Zhang, M., Chu, Z., & Wang, Y. D. (2015). Role of Baicalin in anti- influenza virus A as a potent inducer of IFN-gamma. BioMed rResearch Internationalinternational, 2015, 263630–263611. 2014). https://doi.org/https://doi.org/10.55/2015/263630
- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a A free web tool to evaluate pharmacokinetics, drug- likeness and medicinal chemistry friendliness of small molecules. Scientific ReportsReports, 7(1), 42717. https://doi.org/https://doi.org/10.1038/srep42717
- Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in mMolecular bBiology (Clifton, N.J.)N.J.), 1263, 243–250. https://doi.org/https://doi.org/10.1007/978-1-4939-2269-7_19
- Das, S., Sarmah, S., Lyndem, S., & Roy, A. S. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201
- Dene, R. L., Benjamin, S. G., Rhys, N. C., & Jamie, R. (2020). Crystal structure of the SARS-CoV-2 non-structural protein 9. Nsp9. iscience, 28.https://doi.org/https://doi.org/10.1016/j.isci.2020.101258
- Elfiky, A. A. (2020). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: aAn in silico perspective. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1761882
- Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. Coronaviruses: Methods and Protocols, 1282, 1–23. https://doi.org/https://doi.org/10.1007/978-1-4939-2438-7_1
- Ghali, J. K., Farah, J. O., Daifallah, S., Zabalawi, H. A., & Zimmy, H. D. (2009). Conivaptan and its role in the treatment of hyponatremia. Drug Design, Development and Therapy, 3, 253–268. https://doi.org/https://doi.org/10.2147/dddt.s4505.
- Hendaus, M. A. (2019). Remdesivir in the treatment of coronavirus disease 2019 (COVID- 19): a A simplified summary. Journal of Biomolecular Structure and Dynamics, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.1767691
- Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet (London, England)China. Lancet, 395(10223), 497–506. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30183-5
- Kamal, A., Reddy, B. V. S., Sridevi, B., Ravikumar, A., Venkateswarlu, A., Sravanthi, G., Sridevi, J. P., Yogeeswari, P., & Sriram, D. (2015). Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents. Bioorganic & mMedicinal cChemistry Lettersletters, 25(18), 3867–3872. https://doi.org/https://doi.org/10.1016/j.bmcl.2015.07.057
- Kanchan, A., John, Z., Parvesh, W., Jeroen, R. M., & Rolf, H. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science, 300, 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
- Kato, F., Ishida, Y., Oishi, S., Fujii, N., Watanabe, S., Vasudevan, S. G., Tajima, S., Takasaki, T., Suzuki, Y., Ichiyama, K., Yamamoto, N., Yoshii, K., Takashima, I., Kobayashi, T., Miura, T., Igarashi, T., & Hishiki, T. (2016). Novel antiviral activity of bromocriptine against dengue virus replication. Antiviral ResearchRes, 131, 141–147. https://doi.org/https://doi.org/10.1016/j.antiviral.2016.04.014
- Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., & Singh, E. (2020). Trageting SARS-CoV-2: a A systemic drug repurposing approach to identify promising inhibitors against 3C-protease and 2'-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577
- Kumar, S., Sharma, P. P., Shankar, U., Kumar, D., Joshi, S. K., Pena, L., Durvasula, R., Kumar, A., Kempaiah, P., Poonam, & Rathi, B. (2020). Discovery of new hydroxyethylamine analogs against 3CLpro protein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation and structure-activity relationship studies. Journal of Chemical Information and Modeling, 1–17. https://doi.org/https://doi.org/10.1021/acs.jcim.0c00326
- Kumar, D., Chandel, V., Raj, S., & Rathi, B. (2020). In silico identification of potent FDA approved drugs against coronavirus COVID-19 main protease: A drug repurposing approach. Chemical Biology Letters, 7(3), 166–175.
- Lenard, J. (2008). Viral membranes. Encyclopedia of vVirology, 308–314. https://doi.org/https://doi.org/10.1016/B978-012374410-4.00530-6
- Li, F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annual Review of VirologyVirology, 3(1), 237–261. https://doi.org/https://doi.org/10.1146/annurev-virology-110615-042301
- Lim, K. P., Ng, L. F. P., & Liu, D. X. (2000). Identification of a novel cleavage activity of the first papain-like proteinase domain encoded by open reading frame 1a of the coronavirus avian infectious bronchitis virus and characterization of the cleavage products. Journal of Virologyvirology, 74(4), 1674–1685. https://doi.org/https://doi.org/10.1128/JVI.74.4.1674-1685.2000
- Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A. K., & Gogoi, B. (2020). Potential anti-viral aFctivity of approved repurposed drug against main protease of SARS-CoV-2: aAn in silico based approach. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1768902
- Miura, S. I., Karnik, S. S., & Saku, K. (2011). Angiotensin II type 1 receptor blockers: cClass effects vs. Molecular effects. Journal of the Renin-Angiotensin-Aldosterone SystemSystem, 12(1), 1–7. https://doi.org/https://doi.org/10.1177/1470320310370852
- Mohanraj, K., Karthikeyan, B. S., Vivek-Ananth, R. P., Chand, R. P. B., Aparna, S. R., Mangalapandi, P., & Samal, A. (2018). IMPAAT: A curated database of Indian Medicinal Plants. Scientific Reportsreports, 8(1), 4329. https://doi.org/https://doi.org/10.1038/s41598-018-22631-z
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational ChemistryChemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
- Mousavizadeh, L., & Ghasemi, S. (2020). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology and Infection, 1–5. https://doi.org/https://doi.org/10.1016/j.jmii.2020.03.022
- Nakagawa, K., Lokugamage, K. G., & Makino, S. (2016). Viral and cellular mRNA translation in Coronavirus-infected cells. Advances in vVirus Researchresearch, 96, 165–192. https://doi.org/https://doi.org/10.1016/bs.aivir.2016.08.001
- O’Boyle, N. M., Banck, M., & James, C. A. (2011). Open Babel: An open chemical toolbox. J. Cheminform, 33, 1–14. https://doi.org/https://doi.org/10.1186/1758-2946-3-33
- Pagadala, N. S., Syed, K., & Jack, T. (2017). Software for molecular docking: A review. Biophysical Reviewsreviews, 9(2), 91–102. https://doi.org/https://doi.org/10.1007/s12551-016-0247-1
- Raj, S., Chandel, V., Rathi, B., & Kumar, D. (2020). Understanding the Molecular Mechanism (s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach. Coronaviruses, 1(1), 1–13.
- Robson, B. (2020). COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed Achilles’ heel conserved region to minimize probability of escape mutations and drug resistance. Computers in bBiology and Medicinemedicine, 121, 103749. https://doi.org/https://doi.org/10.1016/j.compbiomed.2020.103749
- Schrödinger Release 2020-1: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY. (2020). Maestro-desmond interoperability tools. Schrödinger.
- Schrödinger Release 2020-1: Maestro, Schrödinger, LLC, New York, NY, 2020. Schrödinger Release 2020-1: Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY. (2016). Impact, Schrödinger, LLC. Prime, Schrödinger, LLC, New York, NY, 2020.
- Seeliger, D., & Groot, B. L. D. (2010). Ligand docking and binding site analysis with PyMOL and Autodock/vina. Journal of cComputer-aAided mMolecular Designdesign, 24(5), 417–422. https://doi.org/https://doi.org/10.1007/s10822-010-9352-6
- Sutton, G., Fry, E., Carter, L., Sainsbury, S., Walter, T., Nettleship, J., Berrow, N., Owens, R., Gilbert, R., Davidson, A., Siddell, S., Poon, L. L. M., Diprose, J., Alderton, D., Walsh, M., Grimes, J. M., & Stuart, D. I. (2004). The nsp9 Replicase Protein of SARS-coronavirus. Structure, 12(2), 341–353. https://doi.org/https://doi.org/10.1016/j.str.2004.01.016
- Touret, F., & Lamballerie, X. d. (2020). Of chloroquine and COVID-19. Antiviral Researchresearch, 177. 104762. https://doi.org/https://doi.org/10.1016/j.antiviral.2020.,
- Vliegen, I., Paeshuyse, J., Zhong, W., & Neyts, J. (2015). In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance. Antiviral ResearchRes, 120, 112–121. https://doi.org/https://doi.org/10.1016/j.antiviral.2015.05.011
- Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. Alexandra, C. W. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181, 281–292. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.058
- Young, J. P., & Alexandra, C. W. (2019). Structure of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. nNature sStructural & mMolecular bBiology, 26, 1151–1157. https://doi.org/https://doi.org/10.1038/s41594-019-0334-7